Laropiprant (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Laropiprant" in English language version.

refsWebsite

Global rank English rank

5nih.gov

4^th place

4doi.org

2^nd place

4semanticscholar.org

11^th place

8^th place

1merck.com

6,464^th place

5,671^st place

1orthomolecular.org

low place

1medicalnewstoday.com

3,011^th place

2,709^th place

1web.archive.org

1^st place

1businessweek.com

712^th place

526^th place

1europa.eu

68^th place

117^th place

1reuters.com

49^th place

47^th place

businessweek.com

Carey J (April 29, 2008). "FDA Rejects Merck's Cordaptive". BusinessWeek. Archived from the original on May 2, 2008. Retrieved 2009-11-13.

doi.org

Sood A, Arora R (November 2009). "Mechanisms of flushing due to niacin and abolition of these effects". Journal of Clinical Hypertension. 11 (11): 685–689. doi:10.1111/j.1559-4572.2008.00050.x. PMC 8673406. PMID 19878384. S2CID 32102745.
Sørensen HT, Mellemkjaer L, Blot WJ, Nielsen GL, Steffensen FH, McLaughlin JK, Olsen JH (September 2000). "Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin". The American Journal of Gastroenterology. 95 (9): 2218–2224. doi:10.1111/j.1572-0241.2000.02248.x. PMID 11007221. S2CID 33742424.
Lai E, De Lepeleire I, Crumley TM, Liu F, Wenning LA, Michiels N, et al. (June 2007). "Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1". Clinical Pharmacology and Therapeutics. 81 (6): 849–857. doi:10.1038/sj.clpt.6100180. PMID 17392721. S2CID 2126240.
Landray MJ, Haynes R, Hopewell JC, Parish S, Aung T, Tomson J, et al. (July 2014). "Effects of extended-release niacin with laropiprant in high-risk patients". The New England Journal of Medicine. 371 (3): 203–212. doi:10.1056/NEJMoa1300955. PMID 25014686. S2CID 23548060.

europa.eu

ema.europa.eu

"Tredaptive European Public Assessment Report" (PDF). European Medicines Agency. Retrieved November 13, 2009.

medicalnewstoday.com

Paddock C (31 August 2009). "For Healthy People Daily Aspirin May Do More Harm Than Good". Medical News Today.

merck.com

"Tredaptive Prescribing Information" (PDF). Merck & Co. Retrieved 2009-11-14.

nih.gov

pubmed.ncbi.nlm.nih.gov

Sood A, Arora R (November 2009). "Mechanisms of flushing due to niacin and abolition of these effects". Journal of Clinical Hypertension. 11 (11): 685–689. doi:10.1111/j.1559-4572.2008.00050.x. PMC 8673406. PMID 19878384. S2CID 32102745.
Sørensen HT, Mellemkjaer L, Blot WJ, Nielsen GL, Steffensen FH, McLaughlin JK, Olsen JH (September 2000). "Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin". The American Journal of Gastroenterology. 95 (9): 2218–2224. doi:10.1111/j.1572-0241.2000.02248.x. PMID 11007221. S2CID 33742424.
Lai E, De Lepeleire I, Crumley TM, Liu F, Wenning LA, Michiels N, et al. (June 2007). "Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1". Clinical Pharmacology and Therapeutics. 81 (6): 849–857. doi:10.1038/sj.clpt.6100180. PMID 17392721. S2CID 2126240.
Landray MJ, Haynes R, Hopewell JC, Parish S, Aung T, Tomson J, et al. (July 2014). "Effects of extended-release niacin with laropiprant in high-risk patients". The New England Journal of Medicine. 371 (3): 203–212. doi:10.1056/NEJMoa1300955. PMID 25014686. S2CID 23548060.

ncbi.nlm.nih.gov

Sood A, Arora R (November 2009). "Mechanisms of flushing due to niacin and abolition of these effects". Journal of Clinical Hypertension. 11 (11): 685–689. doi:10.1111/j.1559-4572.2008.00050.x. PMC 8673406. PMID 19878384. S2CID 32102745.

orthomolecular.org

Kunin RA (1976). "The Action of Aspirin in Preventing the Niacin Flush and its Relevance to the Antischizophrenic Action of Megadose Niacin" (PDF). Orthomolecular Psychiatry. 5 (2): 89–100. Retrieved 2009-11-14.

reuters.com

"Merck withdraws cholesterol drug Tredaptive globally". Reuters. January 11, 2013. Retrieved 11 January 2013.^{[dead link]}

semanticscholar.org

api.semanticscholar.org

Sood A, Arora R (November 2009). "Mechanisms of flushing due to niacin and abolition of these effects". Journal of Clinical Hypertension. 11 (11): 685–689. doi:10.1111/j.1559-4572.2008.00050.x. PMC 8673406. PMID 19878384. S2CID 32102745.
Sørensen HT, Mellemkjaer L, Blot WJ, Nielsen GL, Steffensen FH, McLaughlin JK, Olsen JH (September 2000). "Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin". The American Journal of Gastroenterology. 95 (9): 2218–2224. doi:10.1111/j.1572-0241.2000.02248.x. PMID 11007221. S2CID 33742424.
Lai E, De Lepeleire I, Crumley TM, Liu F, Wenning LA, Michiels N, et al. (June 2007). "Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1". Clinical Pharmacology and Therapeutics. 81 (6): 849–857. doi:10.1038/sj.clpt.6100180. PMID 17392721. S2CID 2126240.
Landray MJ, Haynes R, Hopewell JC, Parish S, Aung T, Tomson J, et al. (July 2014). "Effects of extended-release niacin with laropiprant in high-risk patients". The New England Journal of Medicine. 371 (3): 203–212. doi:10.1056/NEJMoa1300955. PMID 25014686. S2CID 23548060.

web.archive.org

Carey J (April 29, 2008). "FDA Rejects Merck's Cordaptive". BusinessWeek. Archived from the original on May 2, 2008. Retrieved 2009-11-13.